文献速递肾移植

抗-HCV阳性但无病毒血症供者肾脏移植给HCV阴性受者的安全性与临床结局

Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome.
PubMed 文献 · Kidney Int Rep · 2016-10-06

本研究分析抗-HCV阳性供者肾脏移植给HCV阴性受者的结局。2002年9月至2007年5月,51个肾脏(34名供者)抗-HCV反应阳性,其中20名供者(21个肾脏)未检出HCV RNA,移植给21名HCV阴性受者。结果显示无新发HCV感染,5年移植物存活率75%,表明抗-HCV阳性但无病毒血症供者的器官可安全移植给HCV阴性受者。

要点

  • 抗-HCV阳性但HCV RNA阴性的供者肾脏可安全移植给HCV阴性受者。
  • 本研究中HCV阴性受者未发生新发HCV感染。
  • 扩大病毒学筛查未影响中位冷缺血时间,5年移植物存活率75%。

核心结论

  • 抗-HCV反应阳性但无病毒血症的供者器官可安全移植给HCV阴性受者。

研究设计与样本

  • 回顾性分析2002年9月至2007年5月间51个抗-HCV阳性供肾(34名供者)的移植结局。

主要发现

  • 21名HCV阴性受者接受抗-HCV阳性但HCV RNA阴性供者的肾脏,未检测到新发HCV感染。
  • 扩大病毒学供者筛查未影响中位冷缺血时间。
  • 5年移植物存活率为75%。

关键数值与推荐

  • 抗-HCV反应阳性供者需进一步检测HCV RNA,HCV RNA阳性者不适用于HCV阴性受者。
  • 20名供者(21个肾脏)未检出HCV RNA,移植给21名HCV阴性受者。

临床怎么用

  • 对于抗-HCV阳性但HCV RNA阴性的供者,可考虑将其肾脏移植给HCV阴性受者,但需进行扩大的病毒学筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Because of the shortage of available organs for renal transplantation, strategies enabling the safe use of organs from donors with potential chronic infections such as hepatitis C are necessary. The aim of this study was to analyze the outcome of renal transplant donation from hepatitis C virus (HCV)-positive donors. METHODS: Between September 2002 and May 2007, 51 kidneys (34 donors) reactive for HCV antibodies were further evaluated. Six kidneys (5 donors) were transplanted to 6 recipients with known chronic HCV infection. The remaining 29 donors underwent extended virological testing. Nine donors were HCV RNA positive and thus not suitable for HCV-negative patients. Twenty donors (21 kidneys) did not have detectable HCV RNA copies and were transplanted into 21 HCV-negative recipients. Clinical outcomes focusing on safety, allograft function, and de novo HCV infection in the recipient were collected. RESULTS: There were no de novo HCV infections detected in recipients who were HCV negative before transplantation. The extended virological donor screening did not have an impact on median cold ischemia time. Five-year graft survival was 75%. DISCUSSION: Organs from anti-HCV-reactive, nonviremic donors can be transplanted safely to HCV-negative recipients.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Nowak KM, Witzke O, Sotiropoulos GC, et al. Transplantation of Renal Allografts From Organ Donors Reactive for HCV Antibodies to HCV-Negative Recipients: Safety and Clinical Outcome. Kidney Int Rep. 2016. PMID: 29142940. doi:10.1016/j.ekir.2016.09.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。